⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for neck

Every month we try and update this database with for neck cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck CancerNCT00496236
Head and Neck C...
Head and Neck N...
TNFerade biolog...
18 Years - GenVec
Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck CancerNCT00496236
Head and Neck C...
Head and Neck N...
TNFerade biolog...
18 Years - GenVec
Validation of the Turkish Translation of the London Speech Evaluation ScaleNCT04690166
Speech Intellig...
Speech Disorder...
Head and Neck C...
Speech Dysfunct...
Speech
The speech reco...
18 Years - 70 YearsProf. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck CancerNCT00394147
Head and Neck C...
pemetrexed
gemcitabine
18 Years - Fox Chase Cancer Center
Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous TumorNCT00377247
Primary Advance...
Squamous Cell C...
autologous mono...
37 Years - University of Pittsburgh
Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerNCT00226239
Cancer
Docetaxel
Cisplatin
Cetuximab
Radiation Thera...
18 Years - University of Pittsburgh
The Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemNCT00001603
Esophageal Neop...
Head and Neck N...
Laryngeal Neopl...
Papilloma
Squamous Cell C...
- National Institutes of Health Clinical Center (CC)
A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck CancerNCT00496535
Head and Neck C...
Head and Neck N...
TNFerade biolog...
18 Years - GenVec
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)NCT01080066
Carcinoma, Squa...
No Intervention
18 Years - Merck KGaA, Darmstadt, Germany
Immune Therapy of HPV-induced CancersNCT01462838
HPV-induced Can...
P16_37-63
18 Years - Oryx GmbH & Co. KG
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & NeckNCT00195299
Squamous Cell C...
Temsirolimus
18 Years - Wyeth is now a wholly owned subsidiary of Pfizer
Trial of Cetuximab and Pemetrexed With Radiation in Head and Neck CancerNCT00291707
Head and Neck C...
Cetuximab
Pemetrexed
radiation thera...
18 Years - University of Pittsburgh
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck CancerNCT00222729
Cancer
Pemetrexed
Bevacizumab
18 Years - University of Pittsburgh
NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNCT03109158
Carcinoma, Squa...
NC-6004
Cetuximab
5-FU
18 Years - NanoCarrier Co., Ltd.
Study of Topical Superoxide Dismutase to Treat Radiation Induced FibrosisNCT01771991
Radiation Induc...
Topical Sodermi...
Placebo
18 Years - Sanford Health
Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell CarcinomaNCT00596219
SQUAMOUS CELL C...
celecoxib
18 Years - Memorial Sloan Kettering Cancer Center
Window of Opportunity Study of IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell CarcinomaNCT03795610
Head and Neck S...
Head and Neck C...
Head and Neck C...
Head and Neck C...
Head and Neck C...
HPV-Related Car...
HPV-Related Mal...
HPV-Related Squ...
IPI-549
18 Years - University of California, San Diego
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck CancersNCT01166542
Carcinoma, Squa...
REOLYSIN
Carboplatin
Paclitaxel
Placebo
18 Years - Oncolytics Biotech
Myofascial Induction in Breast Cancer SurvivorsNCT02859168
Pain
Breast Cancer
Myofascial Indu...
Unplugged pulse...
25 Years - 65 YearsUniversidad de Granada
The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer TherapyNCT04691310
Lymphedema
Head and Neck C...
Kinesio Taping
Therapy
Kinesio Tex Gol...
18 Years - 70 YearsProf. Dr. Cemil Tascıoglu Education and Research Hospital Organization
Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck CancerNCT01187472
Head and Neck C...
59 Years - University of Chicago
Organ Preservation in the Multispeciality Therapy of Stage II-IV Locally Advanced Head and Neck CancerNCT01187472
Head and Neck C...
59 Years - University of Chicago
The Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemNCT00001603
Esophageal Neop...
Head and Neck N...
Laryngeal Neopl...
Papilloma
Squamous Cell C...
- National Institutes of Health Clinical Center (CC)
Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell CancerNCT01326923
Head and Neck S...
Cetuximab
18 Years - Louisiana State University Health Sciences Center Shreveport
Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerNCT00226239
Cancer
Docetaxel
Cisplatin
Cetuximab
Radiation Thera...
18 Years - University of Pittsburgh
Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor TherapyNCT01967927
Squamous Cell C...
18F-MISO
18 Years - 80 YearsUniversity of Arkansas
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and NeckNCT00519077
Head and Neck N...
Gefitinib
18 Years - University of Chicago
Docetaxel, Cetuximab and Cisplatin Followed by Radiation, Cetuximab and Cisplatin in Head and Neck CancerNCT00226239
Cancer
Docetaxel
Cisplatin
Cetuximab
Radiation Thera...
18 Years - University of Pittsburgh
Immune Therapy of HPV-induced CancersNCT01462838
HPV-induced Can...
P16_37-63
18 Years - Oryx GmbH & Co. KG
Bilateral Elective Neck Dissection in Salvage Total LaryngectomyNCT05746780
Neck Cancer
Larynx
Larynx Cancer
Neck
Elective bilate...
18 Years - 90 YearsFondazione Policlinico Universitario Agostino Gemelli IRCCS
Study of Pemetrexed and Bevacizumab in Patients With Head and Neck CancerNCT00222729
Cancer
Pemetrexed
Bevacizumab
18 Years - University of Pittsburgh
Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck CancersNCT01166542
Carcinoma, Squa...
REOLYSIN
Carboplatin
Paclitaxel
Placebo
18 Years - Oncolytics Biotech
Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck CarcinomaNCT00753038
Carcinoma, Squa...
REOLYSIN®
Carboplatin
Paclitaxel
18 Years - Oncolytics Biotech
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: